Daniella Beckman Blueprint Medicines Corp (BPMC) insider trading activity

Daniella Beckman is Director of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2025, when has been sold 10,842 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Daniella Beckman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 17 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	10,842 Reduced 100.0%	0 Common Stock
Jul 17 2025	SELL Sale (or disposition) back to the issuer	-	3,902 Reduced 26.47%	10,842 Common Stock
Jun 18 2025	BUY Grant, award, or other acquisition	$499,924 $128.12 p/Share	3,902 Added 20.93%	14,744 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	2,242 Added 17.14%	10,842 Common Stock
Jun 21 2023	BUY Grant, award, or other acquisition	-	2,600 Added 23.21%	8,600 Common Stock
Jun 21 2022	BUY Grant, award, or other acquisition	-	2,600 Added 30.23%	6,000 Common Stock

Also insider at

FVAM

5:01 Acquisition Corp. Financial Services

Director

VOR

Vor Biopharma Inc. Healthcare

TBIO

Translate Bio, Inc. Healthcare

Director

TNGX

Tango Therapeutics, Inc. Healthcare

Chief Financial Officer

UPB

Upstream Bio, Inc.